Home » Topics » BioWorld Science

BioWorld Science
RSS

Enanta reports topline phase II data on EDP-305 in primary biliary cholangitis

May 7, 2020

FDA approves Elyxyb for acute treatment of migraine with or without aura

May 7, 2020

Lineage Cell Therapeutics updates phase I/IIa results with OpRegen for dry AMD

May 7, 2020

HIF-1alpha stabilizer GB-004 well tolerated in multiple-dose phase I study

May 7, 2020

DongWha Pharm plans phase II evaluation of DW-2008 for COVID-19

May 7, 2020

New phase III study evaluates lenzilumab in hospitalized patients with COVID-19

May 7, 2020

Amgen reports topline data from phase III study of Otezla for mild to moderate plaque psoriasis

May 7, 2020

New mouse model of mild spinal muscular atrophy

May 7, 2020

EOS-100850 shows excellent tolerance and clinical benefit in refractory solid tumors

May 7, 2020

New SERPINA1 modulators presented by Vertex Pharmaceuticals

May 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...